Efficacy and Safety Study of WVE-210201 (Suvodirsen) With Open-label Extension in Ambulatory Patients With Duchenne Muscular Dystrophy
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Michael A Panzara, MD, MPH
Wave Life Sciences
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
22 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Institut de Myologie
Liège, Liege, Belgium
- Uz Gent
Ghent, Belgium
- Universitaire Ziekenhuizen Leuven
Leuven, Belgium
- Alberta Children'S Hospital
Calgary, Alberta, Canada
- London Health Sciences Centre - Hospital
London, Ontario, Canada
- Fakultni Nemocnice V Motole
Prague, Czechia
- Hôpitaux Universitaires de Strasbourg
Strasbourg, Bas-Rhin, France
- Hôpital Des Enfants
Toulouse, Haute-Garonne, France
- Hopital Armand Trosseau
Paris, France
- Ospedale Pediatrico Bambino Gesù
Rome, Lazio, Italy
- U.O.C Di Neurologia E Malattie Neuromuscolari Centro Clinico Nemo Sud
Messina, Italy
- Ospedale San Reffaele Via Olgettina, 60
Milan, Italy
- Fondazione Policlinico Universitario A Gemelli
Roma, Italy
- Drottning Silvias Barn Och Ungdomssjukhus
Gothenburg, Sweden
- Leeds Teaching Hospitals Nhs Trust
Leeds, United Kingdom
- Great Ormond Street Hospital (gosh)
London, United Kingdom
- Yale University
New Haven, Connecticut, United States
- Rare Disease Research, Llc.
Atlanta, Georgia, United States
- University of Kansas Medical Center
Kansas City, Kansas, United States
- Kennedy Krieger Institute
Baltimore, Maryland, United States
- University of Massachusetts
Worcester, Massachusetts, United States
- Children'S Hospital of Wisconsin
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 4 Sept 2019
- Primary completion
- 16 Dec 2019
- Completion
- 9 Jan 2020
- Last update posted
- 20 May 2021
- Registered enrollment
- 6
- Registry id
- NCT03907072
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.